Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Medios AG

ILM1.DE ✓ COMPLIANT ☆ Track — members

Xetra · Healthcare · Pharmaceuticals ·

Germany Small Cap Analyst: BUY

Last Close

$13.17

▲ +0.53%

Market Cap $334.58M · Vol 27.44K

Key Metrics

P/E Ratio

24.97

FWD: 8.81

Market Cap

$334.58M

Small Cap

Div Yield

0.00%

Annual dividend

EPS Growth

+84.93%

YoY

RSI (14)

33.62

Momentum

Beta

1.12

vs Market

52W High

$20.18

36.10% below

52W Low

$12.49

6.33% above

Volume

27.44K

Avg 38.11K

P/B

0.69

Price-to-book

ROE

3.00%

Return on equity

Free Float

65.20%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Medios AG (ILM1.DE) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ILM1.DE pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.08%

-6.11%

-8.23%

-31.94%

YTD

-21.41%

-21.52%

-26.65%

-70.67%

Financials & Valuation

TTM · Annual

Total Revenue	$2.44B
Net Income	$18.05M
Revenue Growth (YoY)	+7.94%
Gross Margin	7.75%
Operating Margin	2.22%
Net Profit Margin	0.74%
ROE	3.00%
ROA · ROIC	3.04% · 3.53%

P/E Ratio	24.97
Forward P/E (FY1)	8.81
PEG Ratio	1.12
P/S	0.17
P/B	0.69
P/FCF	10.45
EPS Growth	+84.93%
Outstanding Shares	25.51M

Technical Indicators

50-Day SMA	$13.88
200-Day SMA	$15.85
RSI (14)	33.62
Beta	1.12
52-Week High	$20.18
52-Week Low	$12.49

Volume Today	27.44K
Avg Daily Volume (30D)	38.11K
Relative Volume	0.72x
Volatility (10D)	15.59
Volatility (30D)	34.66
Free Float	65.20%

Analyst Consensus

BUY

Current Price $13.17

Mean Target $22.13

52W Low$12.49 52W High$20.18

Current

Target

$12.49 $20.18

Current Analyst target

+68.10% upside potential · 5 analysts

Identifiers

ExchangeXetra

FIGIBBG001S8WPT7

ISINDE000A1MMCC8

CountryGermany

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 11, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.